BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1150362)

  • 1. Studies on the therapeutic use of Mercurascar. Part III. Influence of Mercurascan on some metabolic changes in experimental myocardial ischaemia in dogs. Section I: Energetic and ionic metabolism.
    Kucerová V; Kolc J; Málek P
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):40-51. PubMed ID: 1150362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the therapeutic use of Mercurascar. Part IV: The effect of Mercurascan on some metabolic changes in experimental myocardial ischaemia. Section II: Enzymes.
    Mrhová O; Kolc J; Málek P
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):52-7. PubMed ID: 125244
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the therapeutic use of mercurascan (MSC). Part 2: Antiarrhythmogenic and haemodynamic effect of MSC in experimental myocardial ischaemia.
    Málek P; Vrána M; Kolc J; Netusil M; Blazek Z
    Int J Clin Pharmacol; 1974 Dec; 10(4):273-82. PubMed ID: 4140846
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of short-term microcirculatory disorders on indices of myocardial energy metabolism].
    Chernysheva GV; Vakar MD; Bogdanova EV; Amarantova GG
    Biull Eksp Biol Med; 1977 Nov; 84(11):572-4. PubMed ID: 588733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of energy metabolism of the skeletal muscles in man, dogs and rats during long-term ischemia].
    Molzberger H; Stock W; Heugel W; Welter H; Isselhard W
    Chir Forum Exp Klin Forsch; 1977 Apr; ():135-9. PubMed ID: 618291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the therapeutic use of mercurascan (MSC). Part 1: Distribution of mercurascan in the body in experimental and clinical myocardial ischaemia.
    Málek P; Vavrejn B; Kolc J; Ratuský J
    Int J Clin Pharmacol; 1974 Dec; 10(4):266-72. PubMed ID: 4443131
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic changes in the brains of mice frozen in liquid nitrogen.
    Pontén U; Ratcheson RA; Siesjö BK
    J Neurochem; 1973 Nov; 21(5):1211-6. PubMed ID: 4761706
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional and metabolic effects of terbutaline and propranolol in fast- and slow-contracting skeletal muscle in vitro.
    Fellenius E; Hedberg R; Holmberg E; Waldeck B
    Acta Physiol Scand; 1980 May; 109(1):89-95. PubMed ID: 6255751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional compartmentation of ATP and creatine phosphate in heart muscle.
    Gudbjarnason S; Mathes P; Ravens KG
    J Mol Cell Cardiol; 1970 Sep; 1(3):325-39. PubMed ID: 5519941
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical changes in non-infarcted heart muscle following myocardial infarction.
    Gudbjarnason S; Puri PS; Mathes P
    J Mol Cell Cardiol; 1971 Aug; 2(3):253-76. PubMed ID: 5117219
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values.
    Harris RC; Hultman E; Nordesjö LO
    Scand J Clin Lab Invest; 1974 Apr; 33(2):109-20. PubMed ID: 4852173
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscle ATP content in rheumatoid arthritis--a biopsy study.
    Nordemar R; Lövgren O; Fürst P; Harris RC; Hultman E
    Scand J Clin Lab Invest; 1974 Oct; 34(2):185-91. PubMed ID: 4421764
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in myocardial high energy phosphate levels and left ventricular function after coronary artery occlusion in anaesthetized dogs.
    Puri PS; Gudbjarnason S
    Cardiovasc Res; 1971 Oct; 5(4):451-7. PubMed ID: 5160451
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 2,4-dinitrophenol on energy metabolism in from atria: correlation between changes in metabolism and in K+-ion movements across the membrane.
    Schott A; Siegel G
    Pflugers Arch; 1969; 312(1):R29-31. PubMed ID: 5390235
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective effect of Mercurascan after coronary artery ligation in the dog.
    Málek I; Kolc J; Mrhová O; Urbanová D; Málek P
    Eur J Cardiol; 1980; 12(1):55-62. PubMed ID: 7439234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischaemic preconditioning alters the energy metabolism and protects the ischaemic myocardium in a stepwise fashion.
    Kavianipour M; Ronquist G; Wikström G; Waldenström A
    Acta Physiol Scand; 2003 Jun; 178(2):129-37. PubMed ID: 12780387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral energy metabolism in guinea pig fetuses during development.
    Berger R; Jensen A; Krieglstein J; Steigelmann JP
    J Dev Physiol; 1991 Dec; 16(6):317-9. PubMed ID: 1824113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of creatine, phosphocreatine and adenosinephosphates in experimental hydrocephalus tissue by reversed-phase high performance liquid chromatography].
    Sun AM; Wang ER; Mao BY; Chao RB; Huang X; Xu XC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):113-6. PubMed ID: 14981833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of heart metabolism during infarct healing].
    Braasch W
    Arzneimittelforschung; 1969 May; 19(5):799-802. PubMed ID: 5819793
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical basis of heart function. IV. Energy metabolism and calcium transport in hearts of vitamin E deficient rats.
    Fedelesova M; Sulakhe PV; Yates JC; Dhalla NS
    Can J Physiol Pharmacol; 1971 Oct; 49(10):909-18. PubMed ID: 4400449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.